 FAP - familial adenomatous polyposis  germline mutations in the APC gene (“gatekeeper”)  HNPCC - hereditary nonpolyposis colon cancer (a.k.a. Lynch.

Slides:



Advertisements
Similar presentations
Colon Cancer The life time risk of developing Colon Cancer in the United States in one in sixteen. This means 144,000 new cases a year accounting for.
Advertisements

Pathophysiology Colon CA. Most colorectal cancers, regardless of etiology, arise from adenomatous polyps. Polyp - a grossly visible protrusion from the.
Chapter 12 Genes and Cancer
? BrCA at 44 BrCA at 51 BrCA at 58 Tom Example: Breast Cancer Sporadic Family clusters Hereditary 5%–10% 15%  20% An inherited predisposition.
Genetics of Gastrointestinal Neoplasia 张咸宁 Tel : ; Office: A709, Research Building 2012/04.
Mismatch Repair Deficiency Testing Kenneth J. Bloom, MD, FCAP Chief Medical Officer, Clarient, a GE Healthcare Company.
Cancer: a genetic disease of inherited and somatic mutations n Gene mutations and/or genetic instability are involved in many cancers. n Viruses and environmental.
Gene 210 Cancer Genomics April 29, Key events in investigating the cancer genome M R Stratton Science 2011;331:
Lynch Syndrome and Colorectal Cancer Steven G. Proshan, M.D. Annapolis Colon and Rectal Surgeons Anne Arundel Medical Center November 8,
Risk Assessment for HNPCC
A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD. Department of Medical Genetics.
COLORECTAL BLEEDING: a multidisciplinary approach Torino, 31 marzo-1 aprile 2006 GENETIC EVALUATION Schena M, Angelini F, Bertetto O. Department of Medical.
Hereditary Colon Cancer ACP, October 2013 Steve Lanspa MD, FACP.
Lecture 22 Cancer Genetics II: Inherited Susceptibility to Cancer Stephen B. Gruber, MD, PhD November 19, 2002.
Mechanisms and Epidemiology of Colon Cancer
Hereditary Colorectal Cancer: An Overview Felice Schnoll-Sussman,MD Jay Monahan Center for Gastrointestinal Health New York Hospital/ Weill Cornell Medical.
Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.
Gene 210 Cancer Genomics May 5, Key events in investigating the cancer genome M R Stratton Science 2011;331:
MMR & Hereditary Non-polyposis Colorectal Cancer
MLH 1 and Hereditary Nonpolyposis Colorectal Cancer
MSH2 and Human Nonpolyposis Colon Cancer Yael Aschner.
HNPCC and MLH1 Qi Peng Cancer Biology March 30 th, 2006.
Determining Phenotypes of Pathogenic Mismatch Repair Mutants Brett Palama Lab of Andrew Buermeyer, Ph.D. Dept. of Environmental/Molecular Toxicology.
The Loss of the Cell Cycle Control in Cancer
CMB REVIEW FOR STEP I: Prepared by Pamela L. Derstine, Ph.D. Chromosome Organization Chromosome Organization DNA Replication DNA Replication DNA Repair.
West Midlands Regional Genetics Laboratory
Genetics & Colorectal Cancer
Gene Mutations.
DNA Repair and Cancer. Genome Instability Science, 26 July 2002, p. 544.
Cancer.
Colorectal carcinoma Dr.Mohammadzadeh.
DNA Repair Uracil-DNA Glycosylase. DNA is continually assaulted by damaging agents (oxygen free radicals, ultraviolet light, toxic chemicals). Fortunately,
Cancer.
Angelina Jolie The White Coat Wonder. Rational  The purpose of our research is to enrich the Premed-A community with the knowledge of other cancers caused.
Familial Cancer. General Principles Mutations inherited through germ cells contribute to a minority of tumours Two hits usually needed germline/somatic.
MLH1 & its role in Lynch Syndrome and sporadic colorectal cancers By Annie Jin.
Tumour Analysis-Lynch Syndrome Dr Alan Donaldson Consultant in Clinical Genetics Bristol.
Genetics of Gastrointestinal Neoplasia 张咸宁 Tel : ; Office: A705, Research Building 2013/05.
Bonny Blackard Biology 169 April 4, 2006
DNA Mutations and Repair Chapter 17. Mutation: is defined as an inherited change in genetic information by cell division or individual organisms. Chernobyl,
MSH2 and Hereditary Nonpolyposis Colorectal Cancer By Bobby Glenn Warren III.
Pancreatic Cancer In 2012 there were 43,920 cases of pancreatic cancer. 10% of these cases have a family clustering of pancreatic cancers and associated.
MLH1: Hereditary non- polyposis colon cancer (HNPCC) By: Alison Edge.
Do you have 3 or more affected relatives? (2 or less)
Chapter 11 Cancer Genetics. Cell responses to environmental signals.
Lynch Syndrome or Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
MLH1 and HNPCC March 29, 2005 Tammy Jernigan
Institute of Biomedical & Genetic Engineering (IBGE)
Cancer Can Not Comfort But Your Family Can
Molecular biology of Colorectal Carcinoma (CRC)
Lynch Syndrome: Form, Function, Proteins, and Basketball
Genetics of Cancer Lecture 7
FAMILIAL ADENOMATOUS POLYPOSIS
Mutation Mutation is defined as any permanent, heritable change in sequence or arrangement of genomic DNA. Somatic mutations occur in body cells, and cannot.
CANCER.
MLH1 Mutations and the Formation of Hereditary Non-Polyposis Colon Cancer(Lynch Syndrome) Kevin Harris Hereditary Non-polyposis Colorectal Cancer (HNPCC)
DNA Mutations and Repair
DNA Mutations and Repair
Genomic Instability and Cancer
Genetics Of Cancer Regulation of cell proliferation and cancer
11/29/ /29/2018 Dr Zeinalian.
The Role of MSH2 in Hereditary Non-Polyposis Colon Cancer
Lessons from Hereditary Colorectal Cancer
Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
Noralane M Lindor  Clinical Gastroenterology and Hepatology 
A Knockout for Lynch Syndrome
Lynch Syndrome: Form, Function, Proteins, and Basketball
Colonic polyps and tumors
Inflammatory Bowel Disease (IBD)
Presentation transcript:

 FAP - familial adenomatous polyposis  germline mutations in the APC gene (“gatekeeper”)  HNPCC - hereditary nonpolyposis colon cancer (a.k.a. Lynch syndrome)  germline mutations in DNA mismatch repair genes (“caretaker”)

 autosomal dominant  loss of heterozygosity

 mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)  maps to human chromosome 2p22-21

 heterozygous for mismatch repair genes  hMSH2 and hMLH1 = tumor suppressors

 Black = +/+  Green = G674A / +  solid red = G674A/G674A  blue = -/-  Dotted red = backcross

 the HALMARK of Lynch Syndrome (HNPCC)  Defective MMR = MSI  5 standard DNA markers: *BAT26*

 surgical management – partial colectomy  chemotherapy – need functional MMR  possible preventative treatment › aspirin › resistant starch (fiber)